Health
Eliminate Clozapine REMS, FDA Panels Say - Medscape
Two FDA panels were almost unanimous in their opinion that the agency should eliminate restrictions that psychiatrists and patients say limit access to clozapine.
By: Medscape
- Nov 22 2024
- 0
- 0 Views
Two US Food and Drug Administration (FDA) advisory panels are urging the agency to eliminate the risk management program for the antipsychotic drug clozapine, saying that restrictions are limiting ac… [+8166 chars]